Showing results (21-30 of 66) with videos related to

Sort By:
Pageof 7
European Journal of Cancer (Oxford, England : 1990)|December 20, 2008
Individual patient data analysis to assess modifications to the RECIST criteriaJan Bogaerts, Robert Ford, Dan Sargent, et al.
British Journal of Haematology|October 22, 2016
Survival differences between patients with Hodgkin lymphoma treated inside and outside clinical trials. A study based on the EORTC-Netherlands Cancer Registry linked data with 20 years of follow-upLifang Liu, Francesco Giusti, Michael Schaapveld, et al.
Breast (Edinburgh, Scotland)|September 28, 2010
Pattern of care in locally advanced breast cancer: focus on local therapyMarcin Sinacki, Andrzej Badzio, Marzena Wełnicka-Jaśkiewicz, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 17, 2008
Phase III study comparing exemestane with tamoxifen as first-line hormonal treatment of metastatic breast cancer in postmenopausal women: the European Organisation for Research and Treatment of Cancer Breast Cancer Cooperative GroupRobert J Paridaens, Luc Y Dirix, Louk V Beex, et al.
European Journal of Cancer (Oxford, England : 1990)|December 1, 2006
Postoperative adjuvant chemotherapy followed by adjuvant tamoxifen versus nil for patients with operable breast cancer: a randomised phase III trial of the European Organisation for Research and Treatment of Cancer Breast GroupLeilani Morales, Peter Canney, Jaroslaw Dyczka, et al.
Breast (Edinburgh, Scotland)|July 29, 2014
A phase I pharmacokinetics study of lapatinib and tamoxifen in metastatic breast cancer (EORTC 10053 Lapatam study)Pierre Fumoleau, Kevin M Koch, Etienne Brain, et al.
The Lancet. Oncology|March 1, 2012
Breast conserving therapy versus mastectomy for stage I-II breast cancer: 20 year follow-up of the EORTC 10801 phase 3 randomised trialSaskia Litière, Gustavo Werutsky, Ian S Fentiman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 27, 2022
Meta-Analysis of the Test-Retest Repeatability of [18F]-Fluorodeoxyglucose Standardized Uptake Values: Implications for Assessment of Tumor ResponseLalitha K Shankar, Erich Huang, Saskia Litiere, et al.
Breast (Edinburgh, Scotland)|November 3, 2007
Anti-tumor activity of capecitabine and vinorelbine in patients with anthracycline- and taxane-pretreated metastatic breast cancer: findings from the EORTC 10001 randomized phase II trialBojana Pajk, Tanja Cufer, Peter Canney, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 20, 2012
EORTC 24051: unexpected side effects in a phase I study of TPF induction chemotherapy followed by chemoradiation with lapatinib, a dual EGFR/ErbB2 inhibitor, in patients with locally advanced resectable larynx and hypopharynx squamous cell carcinomaYassine Lalami, Pol M Specenier, Ahmad Awada, et al.
Pageof 7